[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  RayzeBio, Inc. Common Stock (RYZB) RayzeBio (RYZB) is being acquired by Bristol Myers Squibb for $XXXXX per share. Social media engagement is up significantly, reflecting positive sentiment around the acquisition. ### About RayzeBio, Inc. Common Stock RayzeBio, Inc. Common Stock (RYZB) is a stock in the healthcare sector. RayzeBio, Inc. Common Stock uses the ticker $RYZB for trading. Listed in the [Stocks](/list/stocks) and category. ### Insights [#](/topic/$ryzb/insights) - RayzeBio, Inc. Common Stock (RYZB) market dominance near a 52-week low at XXXXXXX. - RayzeBio, Inc. Common Stock (RYZB) social dominance is up XXXXXX% from the previous week. - RayzeBio, Inc. Common Stock (RYZB) engagements is up XXXXXX% from the previous week. ### Price: $XXXXX [#](/topic/$ryzb/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$ryzb/time-series/close.tsv) The price is at $62.50, matching the acquisition price, indicating the market is pricing in the acquisition by Bristol Myers Squibb. **1-Year High**: $XXXXX on 2024-10-20 **1-Year Low**: $XXXXX on 2024-10-20 ### AltRank: XXXXX [#](/topic/$ryzb/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$ryzb/time-series/alt_rank.tsv) RayzeBio, Inc. Common Stock (RYZB) is currently AltRank #1,968 based on combined combined social and market metrics **Daily Average**: XXXXX **1 Week**: XXXXX +1,312 **1 Month**: XXXXX -XX **6 Months**: XXXXX +1,009 **1 Year**: XXXXX +382 **1-Year High**: XXXXX on 2025-08-24 **1-Year Low**: XXX on 2025-04-05 ### Galaxy Score: XXXXX [#](/topic/$ryzb/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$ryzb/time-series/galaxy_score.tsv) **Current Value**: XXXXX **Daily Average**: XX **1 Week**: XX -X **1 Month**: XX -X **6 Months**: XX -X **1 Year**: XX -XX **1-Year High**: XX on 2025-03-02 **1-Year Low**: XX on 2024-10-26 ### Engagements: XX [#](/topic/$ryzb/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$ryzb/time-series/interactions.tsv) **Current Value**: XX **Daily Average**: XXX **1 Week**: XXXXX +226% **1 Month**: XXXXX -XX% **6 Months**: XXXXXX +299% **1 Year**: XXXXXXX -XX% **1-Year High**: XXXXXX on 2025-05-29 **1-Year Low**: X on 2024-10-21 | Social Network | X | | -------------- | - | | Engagements | XX | ### Mentions: X [#](/topic/$ryzb/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$ryzb/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1 Month**: X -XX% **6 Months**: XXX -XX% **1 Year**: XXX -XX% **1-Year High**: XXX on 2024-10-22 **1-Year Low**: X on 2024-10-21 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$ryzb/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$ryzb/time-series/contributors_active.tsv) X unique social accounts have posts mentioning RayzeBio, Inc. Common Stock (RYZB) in the last XX hours which is no change from in the previous XX hours **Daily Average**: X **1 Month**: X -XX% **6 Months**: XX -XX% **1 Year**: XXX -XX% **1-Year High**: XX on 2024-10-22 **1-Year Low**: X on 2024-10-20 The most influential creators that mention RayzeBio, Inc. Common Stock in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@tribepublic](/creator/twitter/tribepublic) | X | XXXXX | X | XXX | [View More](/list/creators/$ryzb/100) ### Social Dominance: XXXXXXXXXXXXXXXXXXXXXX% [#](/topic/$ryzb/social_dominance) ---  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$ryzb/time-series/social_dominance.tsv) **Current Value**: XXXXXXXXXXXXXXXXXXXXXX% **Daily Average**: XXXXXXX% **1 Week**: XXXXXX% +0.00026000000000000003% **1 Month**: XXXXXXX% +0.000029999999999999984% **6 Months**: XXXXXXX% -XXXXXXXXXXXXXXXXXXXXXX% **1 Year**: XXXXXXX% -XXXXXXX% **1-Year High**: XXXXX% on 2024-10-22 **1-Year Low**: XXXXXX% on 2025-07-06 ### Market Dominance: XXXXXXX% [#](/topic/$ryzb/market_dominance) ---  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$ryzb/time-series/market_dominance.tsv) **Current Value**: XXXXXXX% **Daily Average**: X% **1-Year High**: XXXXXXX% on 2025-04-08 **1-Year Low**: XXXXXX% on 2025-10-06 **Top assets mentioned** In the posts about RayzeBio, Inc. Common Stock in the last XX hours [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Karuna Therapeutics, Inc. Common Stock (KRTX)](/topic/$krtx) [Tourmaline Bio, Inc. Common Stock (TRML)](/topic/$trml) [Akropolis (AKRO)](/topic/$akro) **Top topics mentioned** In the posts about RayzeBio, Inc. Common Stock in the last XX hours [stocks healthcare](/topic/stocks-healthcare), [$bmy](/topic/$bmy), [$cytk](/topic/$cytk), [$krtx](/topic/$krtx), [$myok](/topic/$myok), [$avtx](/topic/$avtx), [$trml](/topic/$trml), [$akro](/topic/$akro), [$stok](/topic/$stok) ### Top Social Posts [#](/topic/$ryzb/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$BMY patent cliff is a huge problem for the company. Expensive acquisitions $KRTX $MYOK (Camzyos sales accelerating but $CYTK might have the better drug) $MRTX $RYZB and $CELG in the past. BMS needs commercial drug assets imo. $MDGL $BBIO $AXSM $NBIX $TLX" [X Link](https://x.com/doepke_michel/status/1977369129972650327) [@doepke_michel](/creator/x/doepke_michel) 2025-10-12T13:41Z 5621 followers, 8253 engagements "$avtx $trml $akro $stok $ryzb $xbi what do they all have in common. Aaron Kantoff" [X Link](https://x.com/badinvestor99/status/1976629757128352093) [@badinvestor99](/creator/x/badinvestor99) 2025-10-10T12:43Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
RayzeBio (RYZB) is being acquired by Bristol Myers Squibb for $XXXXX per share. Social media engagement is up significantly, reflecting positive sentiment around the acquisition.
RayzeBio, Inc. Common Stock (RYZB) is a stock in the healthcare sector.
RayzeBio, Inc. Common Stock uses the ticker $RYZB for trading. Listed in the Stocks and category.
Price 24-Hour Time-Series Raw Data
The price is at $62.50, matching the acquisition price, indicating the market is pricing in the acquisition by Bristol Myers Squibb.
1-Year High: $XXXXX on 2024-10-20
1-Year Low: $XXXXX on 2024-10-20
AltRank 24-Hour Time-Series Raw Data
RayzeBio, Inc. Common Stock (RYZB) is currently AltRank #1,968 based on combined combined social and market metrics
Daily Average: XXXXX
1 Week: XXXXX +1,312
1 Month: XXXXX -XX
6 Months: XXXXX +1,009
1 Year: XXXXX +382
1-Year High: XXXXX on 2025-08-24
1-Year Low: XXX on 2025-04-05
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -X
1 Month: XX -X
6 Months: XX -X
1 Year: XX -XX
1-Year High: XX on 2025-03-02
1-Year Low: XX on 2024-10-26
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXXXX +226%
1 Month: XXXXX -XX%
6 Months: XXXXXX +299%
1 Year: XXXXXXX -XX%
1-Year High: XXXXXX on 2025-05-29
1-Year Low: X on 2024-10-21
Social Network | X |
---|---|
Engagements | XX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Month: X -XX%
6 Months: XXX -XX%
1 Year: XXX -XX%
1-Year High: XXX on 2024-10-22
1-Year Low: X on 2024-10-21
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning RayzeBio, Inc. Common Stock (RYZB) in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Month: X -XX%
6 Months: XX -XX%
1 Year: XXX -XX%
1-Year High: XX on 2024-10-22
1-Year Low: X on 2024-10-20
The most influential creators that mention RayzeBio, Inc. Common Stock in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@tribepublic | X | XXXXX | X | XXX |
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXXXXXXXXXXXXXXXXX%
Daily Average: XXXXXXX%
1 Week: XXXXXX% +0.00026000000000000003%
1 Month: XXXXXXX% +0.000029999999999999984%
6 Months: XXXXXXX% -XXXXXXXXXXXXXXXXXXXXXX%
1 Year: XXXXXXX% -XXXXXXX%
1-Year High: XXXXX% on 2024-10-22
1-Year Low: XXXXXX% on 2025-07-06
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2025-04-08
1-Year Low: XXXXXX% on 2025-10-06
Top assets mentioned In the posts about RayzeBio, Inc. Common Stock in the last XX hours
Bristol-Myers Squibb Co (BMY) Cytokinetics Inc. (CYTK) Karuna Therapeutics, Inc. Common Stock (KRTX) Tourmaline Bio, Inc. Common Stock (TRML) Akropolis (AKRO)
Top topics mentioned In the posts about RayzeBio, Inc. Common Stock in the last XX hours
stocks healthcare, $bmy, $cytk, $krtx, $myok, $avtx, $trml, $akro, $stok
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$BMY patent cliff is a huge problem for the company. Expensive acquisitions $KRTX $MYOK (Camzyos sales accelerating but $CYTK might have the better drug) $MRTX $RYZB and $CELG in the past. BMS needs commercial drug assets imo. $MDGL $BBIO $AXSM $NBIX $TLX"
X Link @doepke_michel 2025-10-12T13:41Z 5621 followers, 8253 engagements
"$avtx $trml $akro $stok $ryzb $xbi what do they all have in common. Aaron Kantoff"
X Link @badinvestor99 2025-10-10T12:43Z XXX followers, XXX engagements
/topic/$ryzb